Incidence of cardiac arrhythmias in patients with COVID-19 infection according to 24-hour electrocardiogram monitoring

Authors

  • V. O. Zbitnieva Odessa National Medical University, Ukraine, Ukraine https://orcid.org/0000-0001-9656-4860
  • O. B. Voloshyna Odessa National Medical University, Ukraine, Ukraine
  • I. V. Balashova Odessa National Medical University, Ukraine, Ukraine
  • O. R. Dukova Odessa National Medical University, Ukraine, Ukraine
  • I. S. Lysyi Odessa National Medical University, Ukraine, Ukraine

DOI:

https://doi.org/10.14739/2310-1210.2021.6.239243

Abstract

Cardiac arrhythmias in patients with COVID-19 infection may be due to many pathophysiological factors. Further study on the structure of arrhythmias in this category of patients will reveal clinically significant arrhythmias and select the optimal management.

The aim: to determine the features of arrhythmias in patients with and without concomitant cardiovascular disease who suffered from COVID-19 infection based on the results of 24-hour electrocardiogram (ECG) monitoring.

Materials and methods. 84 patients (45 men – 53.5 %, 39 women – 46.5 %) who had COVID-19 infection over 12 weeks previously were examined. Patients were divided into 2 groups – with and without a history of concomitant cardiovascular disease. The patient groups did not differ in age (P = 0.33) and sex (P = 0.58, P = 0.64). 24-hour ECG monitoring was performed on a Cardiosens K device (XAI-MEDICA, Kharkiv) according to the standard method.

Results. Comparison of 12-channel ECG data did not reveal a significant difference in the incidence of single atrial (P = 0.13) and ventricular extrasystoles (P = 0.37) between the two groups, but sinus tachycardia was significantly more common in patients without concomitant cardiovascular disease (P = 0.022). According to 24-hour ECG monitoring, a significantly higher total number of arrhythmias, in particular, supraventricular extrasystoles (P = 0.009), high gradations of ventricular arrhythmias: paired ventricular extrasystoles (P = 0.041), ventricular bigeminy (P = 0.005), ventricular trigeminy (P = 0.004), ventricular salvos (P = 0.017) were detected significantly more frequently in patients with concomitant cardiovascular disease after COVID-19 infection than those in the comparison group. The results of 24-hour ECG monitoring also showed that patients without cardiovascular disease were significantly more likely to have inappropriate sinus tachycardia (P = 0.03) and postural orthostatic tachycardia (P = 0.04). Paroxysmal arrhythmias were significantly more common in patients with concomitant cardiovascular pathology, namely unstable (P = 0.002) and stable paroxysms of atrial tachycardia (P = 0.014), unstable paroxysms of monomorphic ventricular tachycardia (8.3 %), paroxysms of atrial fibrillation (6.2 %).

Conclusions. 24-hour ECG monitoring should be advised in patients with COVID-19 infection and concomitant cardiovascular disease in addition to recording a standard 12-channel ECG to detect prognostically unfavorable cardiac arrhythmias, possible arrhythmogenic manifestations of post-COVID-19 syndrome and choose management tactics for these patients.

Author Biographies

V. O. Zbitnieva, Odessa National Medical University, Ukraine

MD, PhD, Assistant of the Department of General Practice

O. B. Voloshyna, Odessa National Medical University, Ukraine

MD, PhD, DSc, Professor, Head of the Department of General Practice

I. V. Balashova, Odessa National Medical University, Ukraine

MD, PhD, Assistant of the Department of General Practice

O. R. Dukova, Odessa National Medical University, Ukraine

MD, PhD, Associate Professor of the Department of General Practice

I. S. Lysyi, Odessa National Medical University, Ukraine

MD, PhD, Associate Professor of the Department of General Practice

References

Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020). Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology, 5(7), 831-840. https://doi.org/10.1001/jamacardio.2020.1286

Zhao, M., Wang, M., Zhang, J., Ye, J., Xu, Y., Wang, Z., Ye, D., Liu, J., & Wan, J. (2020). Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomedicine & Pharmacotherapy, 127, Article 110230. https://doi.org/10.1016/j.biopha.2020.110230

Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(3), 247-250. https://doi.org/10.1016/j.dsx.2020.03.013

Zhang, D., Shen, X., & Qi, X. (2016). Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ, 188(3), E53-E63. https://doi.org/10.1503/cmaj.150535

Dhakal, B. P., Sweitzer, N. K., Indik, J. H., Acharya, D., & William, P. (2020). SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart, Lung and Circulation, 29(7), 973-987. https://doi.org/10.1016/j.hlc.2020.05.101

Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y., … China Medical Treatment Expert Group for Covid-19. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18), 1708-1720. https://doi.org/10.1056/NEJMoa2002032

Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5(7), 811-818. https://doi.org/10.1001/jamacardio.2020.1017

Desai, A. D., Boursiquot, B. C., Melki, L., & Wan, E. Y. (2020). Management of Arrhythmias Associated with COVID-19. Current Cardiology Reports, 23(1), Article 2. https://doi.org/10.1007/s11886-020-01434-7

Buheruk, V. V., Vоlоshyna, O. B., & Balashova, I. V. (2021). Zapalne urazhennia miokarda u khvorykh na koronavirusnu khvorobu 2019 (COVID-19) [Inflammatory damage to the myocardium in patients with novel coronavirus disease (COVID-19)]. Zaporozhye medical journal, 23(4), 555-566. https://doi.org/10.14739/2310-1210.2021.4.211033 [in Ukrainian].

Ministry of Health of Ukraine. (2016, March 3). Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry stabilnii ishemichnii khvorobi sertsia [On approval and implementation of medical and technological documents for standardization of medical care for stable coronary heart disease (No. 152)]. https://zakon.rada.gov.ua/laws/show/z0069-03

Ministry of Health of Ukraine. (2012, May 24). Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry arterialnii hipertenzii [On approval and implementation of medical and technological documents for standardization of medical care for hypertension (No. 384)]. https://zakon.rada.gov.ua/rada/show/v0384282-12#Text

Voronkov, L. H., Amosova, K. M., Dziak, H. V., Zharinov, O. Y., Kovalenko, V. M., Korkushko, O. V., Nesukai, O. H., Sychov, O. S., Rudyk, Yu. S., & Parkhomenko, O. M. (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany, (1, dodatok 1), 1-66. [in Ukranian].

European Society of Cardiology. (2019). 2019 Guidelines on Chronic Coronary Syndromes. ESC Clinical Practice Guidelines. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes

European Society of Cardiology. (2018). 2018 ESC/ESH Clinical Practice Guidelines for the Management of Arterial Hypertension. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Arterial-Hypertension-Management-of

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J., Coats, A., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37(27), 2129-2200. https://doi.org/10.1093/eurheartj/ehw128

European Society of Cardiology. (2015). Pocket Guidelines on Ventricular Arrhythmias and Sudden Cardiac Death. ESC Pocket Guidelines. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Guidelines-derivative-products/Pocket-Guidelines/Ventricular-Arrythmias-and-Sudden-Cardiac-Death

Zharinov, O. Y., Ivaniv, Yu. A., & Kuts, V. O. (Eds.). (2021). Funktsionalna diahnostyka [Functional diagnostics](2nd ed.). Chetverta khvylia

Published

2021-10-29

How to Cite

1.
Zbitnieva VO, Voloshyna OB, Balashova IV, Dukova OR, Lysyi IS. Incidence of cardiac arrhythmias in patients with COVID-19 infection according to 24-hour electrocardiogram monitoring. Zaporozhye Medical Journal [Internet]. 2021Oct.29 [cited 2024Oct.5];23(6):759-65. Available from: http://zmj.zsmu.edu.ua/article/view/239243

Issue

Section

Original research